PL442301A1 - Preparat farmaceutyczny zawierający genisteinę do zastosowania w profilaktyce lub leczeniu jaskry i/lub nadciśnienia ocznego - Google Patents
Preparat farmaceutyczny zawierający genisteinę do zastosowania w profilaktyce lub leczeniu jaskry i/lub nadciśnienia ocznegoInfo
- Publication number
- PL442301A1 PL442301A1 PL442301A PL44230122A PL442301A1 PL 442301 A1 PL442301 A1 PL 442301A1 PL 442301 A PL442301 A PL 442301A PL 44230122 A PL44230122 A PL 44230122A PL 442301 A1 PL442301 A1 PL 442301A1
- Authority
- PL
- Poland
- Prior art keywords
- pharmaceutical preparation
- glaucoma
- treatment
- ocular hypertension
- prevention
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Przedmiotem wynalazku jest preparat farmaceutyczny do zastosowania w profilaktyce lub leczeniu, nadciśnienia ocznego i/lub jaskry u pacjenta, zawierający farmaceutycznie dopuszczalny nośnik, rozcieńczalnik, środek pomocniczy i/lub substancję wspomagającą, charakteryzujący się tym, że zawiera genisteinę w ilości od 10 do 15% wag. w odniesieniu do całkowitej masy preparatu farmaceutycznego, który również występuje w postaci kapsułki z otoczką HPMC.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP23197564.0A EP4338798A1 (en) | 2022-09-16 | 2023-09-15 | Pharmaceutical preparation containing genistein for use in the prevention or treatment of glaucoma and/or ocular hypertension |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL43897121 | 2021-09-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL442301A1 true PL442301A1 (pl) | 2023-03-20 |
Family
ID=85685853
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL442301A PL442301A1 (pl) | 2021-09-17 | 2022-09-16 | Preparat farmaceutyczny zawierający genisteinę do zastosowania w profilaktyce lub leczeniu jaskry i/lub nadciśnienia ocznego |
Country Status (1)
Country | Link |
---|---|
PL (1) | PL442301A1 (pl) |
-
2022
- 2022-09-16 PL PL442301A patent/PL442301A1/pl unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11267799B2 (en) | Solid forms of an HIV capsid inhibitor | |
Rosenbaum et al. | Adjustable rectus muscle recession surgery: a follow-up study | |
MX2021012903A (es) | Moduladores de la via de respuesta integrada al estres. | |
MX2021005945A (es) | Ureas ciclicas. | |
NO20065638L (no) | Formuleringer med kontrollert frigivelse inneholdende vardenafil | |
PH12014500937A1 (en) | 5-ht 1a receptor substype agonist | |
EA202090029A1 (ru) | Твердая композиция карипразина для орального введения | |
HUP0400200A2 (hu) | Gyógyászati készítmény apomorfin, 6aR-(-)-N-propil-norapomorfin és származékai, valamint prodrugjai hatékony adagolására | |
MX2021012904A (es) | Moduladores de la via de respuesta al estres integrada. | |
RU2018136580A (ru) | Цитратная соль (s)-4-((s)-3-фтор-3-(2-(5,6,7,8-тетрагидро-1,8-нафтиридин-2-ил)этил)пирролидин-1-ил)-3-(3-(2-метоксиэтокси)фенил)бутановой кислоты | |
WO2005092307A3 (en) | Pharmaceutical dosage forms and compositions of 5-ht1a receptor antagonists | |
MX2022009243A (es) | Moduladores de la via de respuesta integrada al estres. | |
DK1641461T3 (da) | Kombinationsprodukt omfattende en histamin H3 receptor antagonist eller invers agonist og et antipsykotisk eller antidepressivt middel, og anvendelse deraf i fremstillingen af et medikament som forebygger de negative virkninger af psykotropiske ... | |
MA53927B1 (fr) | Composition pharmaceutique pour une administration par voie orale comprenant un dérivé d'aminopyrimidine ou son sel | |
AU2020278236A8 (en) | Methods of treating Sjögren's Syndrome using a Bruton's tyrosine kinase inhibitor | |
NO20032261L (no) | Medisinske preparater | |
HUP0302718A2 (hu) | Eljárások és készítmények szembetegségek kezelésére | |
PL442301A1 (pl) | Preparat farmaceutyczny zawierający genisteinę do zastosowania w profilaktyce lub leczeniu jaskry i/lub nadciśnienia ocznego | |
WO2008005352A3 (en) | Solid dose formulations of a thrombin receptor antagonist | |
US20050107438A1 (en) | Pharmaceutical composition comprising 3-[(2-{[4-(Hexyloxycarbonylaminoiminomethyl) phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester or a salt therefore | |
WO2016189406A1 (en) | Pharmaceutical composition of teriflunomide | |
ZA202200331B (en) | Naltrexone formulation | |
Djavan | α1-Adenoceptor Antagonists for the Treatment of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): State of the Art | |
US20100168191A1 (en) | Pharmaceutical formulation comprising pramipexole | |
US20090124606A1 (en) | Composition for Treatment of Psychosis |